Results 41 to 50 of about 160,934 (305)

“ANALISIS PENGARUH DEBT TO EQUITY RATIO, FINANCIAL DISTRESS, FIRM SIZE, GROWTH OPPORTUNITY, INSTITUTIONAL OWNERSHIP DAN LIQUIDITY TERHADAP PENGAMBILAN KEPUTUSAN HEDGING MENGGUNAKAN INSTRUMEN DERIVATIF (Studi pada Perusahaan Manufaktur dan Perusahaan ESDM yang Terdaftar di BEI Periode 2010-2014)” [PDF]

open access: yes, 2016
Hedging is one of the alternatives of risk management that aims to protect assets of company from losses caused by the risk. The purpose of this research is to analyze the influence of independent variables which include DER, Financial Distress, Firm ...
PANGESTUTI, Irene Rini Demi   +1 more
core  

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

open access: yesMolecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed   +10 more
wiley   +1 more source

Perspectives in educating molecular pathologists on liquid biopsy: Toward integrative, equitable, and decentralized precision oncology

open access: yesMolecular Oncology, EarlyView.
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié   +13 more
wiley   +1 more source

Исследование производных финансовых инструментов хеджирования валютных рисков [PDF]

open access: yes, 2018
THE REASERCH OF DERIVATIVE FINANCIAL INSTRUMENTS HEDGING CURRENCY RISKS I. STROGANOVАИсследуются свойства и выявляются особенности производных финансовых инструментов хеджирования валютных рисков.
Строганова, И. А.
core   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

FINANCIAL ANALYSIS FOR TRANSACTION WITH FINANCIAL TOOLS AT OMV PETROM CITY ROMANIA [PDF]

open access: yesAnnals of the University of Petrosani: Economics, 2017
Through this paper the authors approach the sphere of financial instruments on the capital market. Their conceptual evolution is influenced by both the relationship between the accounting and financial approach and the degree of use for financial ...
ILIE RĂSCOLEAN, ILEANA-SORINA RAKOS
doaj  

Swaps and financial derivatives: risks and returns

open access: yesPSL Quarterly Review, 2013
Derivative financial products have experienced a huge expansion during recent years. New products are constantly appearing which seek to expand the scope of risk diversification.
R.S. MASERA
doaj   +1 more source

The risks of operations with derivative financial instruments as a threat to the financial stability of commercial banks

open access: yesЕкономіка, управління та адміністрування, 2023
The article discusses the risks of the operations of commercial banks with derivative financial instruments. The emergence of new types of derivatives for the Ukrainian financial market in recent years, the establishment of provisions on defining their ...
O.V. , A.O.
doaj   +1 more source

Eroding market stability by proliferation of financial instruments

open access: yes, 2008
We contrast Arbitrage Pricing Theory (APT), the theoretical basis for the development of financial instruments, with a dynamical picture of an interacting market, in a simple setting.
A. Martino De   +16 more
core   +2 more sources

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy